9/26/2022 6:50:27 AM
Pfizer, BioNTech Submit Application To FDA For EUA Of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster In Children
9/16/2022 8:13:14 AM
Pfizer, BioNTech Get Positive CHMP Opinion For Conversion Of COMIRNATY To Full Marketing Authorization
9/12/2022 11:34:24 AM
Pfizer And BioNTech Receive Positive CHMP Opinion For Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster In EU
9/1/2022 9:33:42 AM
EMA's CHMP Recommends Updated Covid-19 Booster Doses From Pfizer-BioNTech, Moderna
8/26/2022 9:55:13 AM
Pfizer , BioNTech Complete Submission To EMA For Omicron BA.4/BA.5 Adapted Bivalent Vaccine
8/26/2022 8:16:36 AM
Moderna Sues Pfizer And BioNTech For Infringing Patents Central To Moderna's Innovative MRNA Technology Platform
8/23/2022 6:48:23 AM
Pfizer, BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy In Children 6 Months Through 4 Years Of Age
8/22/2022 10:37:36 AM
Pfizer & BioNTech Submit Application To FDA For EUA Of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine
8/8/2022 6:03:35 AM
BioNTech Q2 EPS EUR 6.45 Vs EUR 10.77 Last Year